Ex Parte Ozeki et al - Page 4




              Appeal No. 2006-0108                                                                                                             
              Application No. 09/980,620                                                                                                       

              further limit claims if it merely states a purpose or intended use of subject matter.  See                                       
              Kropa v. Robie, 187 F.2d 150, 152, 88 USPQ 478, 481(CCPA 1951).                                                                  
                     In the present case, we do not find that the claim preamble, "sleep promoting"                                            
              offers a distinct definition of any of the claimed invention's limitations, but rather merely                                    
              states, for example, the purpose or intended use of the theanine composition.  Thus,                                             
              with respect to the composition claims, we do not find that the claim preamble "sleep                                            
              promoting," further limits the claims.  In view of this claim interpretation, appellants claim                                   
              1 claims a composition comprising theanine.  Kakuda describes a composition                                                      
              comprising theanine (abstract).  We affirm the examiner's rejection as Kakuda                                                    
              anticipates claim 1.  Claims 2 and 3 fall with claim 1.                                                                          
                     Claim 4, a method claim, stands on a different footing than the composition                                               
              claims.  Claim 4 describes a method wherein the theanine is administered to an                                                   
              individual having sleep disorders.  The examiner has not indicated, and we do not find,                                          
              where Kakuda describes administration of theanine to an individual having a sleep                                                
              disorder.                                                                                                                        
                     We acknowledge the examiner's indication (Answer, page 7) that Kakuda                                                     
              describes that the disclosed theanine containing composition "does not impair sleep,"                                            
              but we fail to see how such a statement provides for the administration of theanine to an                                        
              individual having a sleep disorder.  Thus, we agree with appellants, that with respect to                                        
              method claim 4, the examiner has not provided evidence to support a prima facie case                                             
              of anticipation.  The rejection of claim 4 for anticipation over Kakuda is reversed.                                             


                                                           4                                                                                   













Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007